Financials

Discussions Technicals Seasonals

DNA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

DNA Group (T.R.) Ltd. engages in investing in biomedical companies and real estate. Through its portfolio companies, it provides ultrasound systems for diagnosing bone strength and density and monitoring calcium leakage, as well as oral drugs for the treatment of osteoporosis. The company was founded on October 24, 2004 and is headquartered in Tel Aviv, Israel.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

DNA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company